Nulojix
Nulojix ingredients
| Active ingredient | Strength |
|---|---|
| Belatacept | 250 mg/1 |
What Nulojix is used for
The FDA lists the approved uses on the official label (below). In the EU, belatacept is approved as Nulojix for:
Nulojix, in combination with corticosteroids and a mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Nulojix
- Generic name
- Belatacept
- Made by
- E.R. Squibb & Sons, L.L.C.
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous
- Drug class
- Selective T Cell Costimulation Blocker
- FDA approval
- Biologic licence (BLA) BLA125288
- On the US market since
- 2011
Official information
- Nulojix prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Belatacept)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Nulojix?
Nulojix (Belatacept) is a specialist medicine made by E.R. Squibb & Sons, L.L.C., approved by the US FDA.
What are the ingredients of Nulojix?
Nulojix contains Belatacept (250 mg/1).
Is Nulojix approved in Europe?
The same active substance is approved in the EU as Nulojix.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA